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Abstract
Background: Decreases in length of stay (LOS) in hospital after breast cancer surgery can be
partly attributed to the change to less radical surgery, but many other factors are operating at the
patient, surgeon and hospital levels. This study aimed to describe the changes in and predictors of
length of stay (LOS) in hospital after surgery for breast cancer between 1997/98 and 2004/05 in
two regions of England.
Methods: Cases of female invasive breast cancer diagnosed in two English cancer registry regions
were linked to Hospital Episode Statistics data for the period 1st April 1997 to 31st March 2005. A
subset of records where women underwent mastectomy or breast conserving surgery (BCS) was
extracted (n = 44,877). Variations in LOS over the study period were investigated. A multilevel
model with patients clustered within surgical teams and NHS Trusts was used to examine
associations between LOS and a range of factors.
Results: Over the study period the proportion of women having a mastectomy reduced from 58%
to 52%. The proportion varied from 14% to 80% according to NHS Trust. LOS decreased by 21%
from 1997/98 to 2004/05 (LOSratio = 0.79, 95%CI 0.77-0.80). BCS was associated with 33%
shorter hospital stays compared to mastectomy (LOSratio = 0.67, 95%CI 0.66-0.68). Older age,
advanced disease, presence of comorbidities, lymph node excision and reconstructive surgery were
associated with increased LOS. Significant variation remained amongst Trusts and surgical teams.
Conclusion: The number of days spent in hospital after breast cancer surgery has continued to
decline for several decades. The change from mastectomy to BCS accounts for only 9% of the
overall decrease in LOS. Other explanations include the adoption of new techniques and practices,
such as sentinel lymph node biopsy and early discharge. This study has identified wide variation in
practice with substantial cost implications for the NHS. Further work is required to explain this
variation.
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Background
The average time spent in hospital after treatment has
been decreasing for many years. Data show that in the UK
the average length of stay (LOS) for patients receiving
acute care decreased from 19.8 days in 1953 to 8.8 days in
1982[1]. More recent data show that the decrease has con-
tinued and by 2005 the average LOS was 6.1 days[2]. Sim-
ilar reductions have been seen in most developed
countries.
LOS can vary according to a wide range of factors, includ-
ing patient, physician and hospital characteristics [3-5].
Patient characteristics associated with increased hospital
stays include older age, being unmarried or having no
immediate family, lower socioeconomic status, more
severe illness and presence of comorbidity [4-6]. Physi-
cian characteristics, such as age, level of experience and
number of cases treated per year may have an effect on
LOS. For example, younger, less experienced doctors may
keep patients in hospital for longer than their older, more
experienced colleagues[7]. Alternatively, those doctors
trained more recently may opt to use less invasive tech-
niques leading to shorter hospital stays. Finally, hospital
characteristics, including hospital size or number of beds
available and hospital discharge policy are likely to have
an effect on LOS. In addition, the hospital-level LOS will
be influenced by the population living within it's catch-
ment area; if the population is more deprived and has a
higher level of pre-existing illness then the overall LOS is
likely to be longer[3,6].
The reductions in LOS for breast cancer patients appear to
have been even greater. A study carried out in Canada
reported that the average LOS for breast cancer patients
undergoing surgery in the 1980s was approximately 3
days longer than that for all surgery patients combined,
but by 2000 the average LOS for breast cancer patients was
half the overall average[8]. Data from 22 European coun-
tries show substantial decreases in the average LOS for
breast cancer patients between 1990 and 2005; the UK
average decreased from 9.8 days in 1990 to 5.2 days in
2005[9].
One of the major changes in the treatment of breast cancer
in recent decades is the change from mastectomy to breast
conserving surgery (BCS), which is a less radical operation
and therefore generally requires less time in hospital after-
wards. In a study of Swedish breast cancer patients,
Lindqvist et al estimated that 14% of decline seen in LOS
could be attributed to the change from mastectomy to
BCS[10]. At the same time there has been a move towards
less invasive axillary surgery (from axillary node dissec-
tion to sampling and, more recently, sentinel lymph node
biopsy [SLNB]), which may also explain some of the
reduction in LOS. A further recent development is that of
early discharge, where women leave hospital one or two
days after surgery, and in some cases on the same day,
with wound drains still in place, after it was shown that
such practice did not result in increased rates of physical
or psychological illness[11]. Other factors affecting LOS
may include changes in casemix (towards younger
patients with less advanced disease), the increasing spe-
cialisation of surgeons, and hospital policy in response to
financial pressures.
Many health data, such as those used to investigate trends
in surgical treatment and LOS, have an inherent cluster-
ing. For example, patients are managed by surgeons, who
in turn are clustered within hospitals. Failure to account
for this clustering can lead to bias in the resulting esti-
mates; there may be effects due to variation in a surgeon's
willingness to discharge early or aspects of the hospital
resources. By using multilevel modelling it is possible to
obtain more accurate estimates and in addition the
amount of variation attributable to each level can be esti-
mated. This methodology was used by Westert et al when
looking at variations in duration of hospital stay for four
(non-cancer) operations[12]. They found that the varia-
tion between hospitals was much larger than that within
hospitals (i.e. between doctors). However, the breast can-
cer focused studies mentioned above used only standard
regression techniques.
The aim of this study was to describe the changes in and
predictors of LOS in hospital after surgery for breast can-
cer between 1997/98 and 2004/05 in two regions of Eng-
land using multilevel modelling.
Methods
The study dataset
Cases of female invasive breast cancer diagnosed in the
Northern & Yorkshire and West Midlands cancer registry
regions between 1997 and 2005 were identified from the
respective cancer registry databases. These two registries
have high quality staging and treatment data and cover
approximately 23% of the population of England, 35 of
the 168 Acute NHS Trusts in the country and are broadly
representative in terms of population structure and level
of deprivation. The cancer registry data were linked (using
all or combinations of the identifiers of NHS number,
date of birth and postcode at diagnosis) to an extract of
Hospital Episode Statistics (HES) data covering the time
period of April 1997 to March 2005. The study team have
been granted MREC and NIGB approvals to hold and link
the data.
A subset of the linked records where women underwent
mastectomy or BCS was extracted (n = 44 877). Where
women underwent both types of operation, the record
relating to the most radical surgery (mastectomy) wasBMC Health Services Research 2009, 9:202 http://www.biomedcentral.com/1472-6963/9/202
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chosen. Where women underwent the same operation on
more than one occasion the first operation was chosen.
Patient age and stage of disease were obtained from the
cancer registry data. A measure of comorbidity was
derived using non-breast cancer diagnoses recorded in the
year before surgery (in any of the 14 diagnosis codes in
HES) according to the Charlson Index[13]. Using the
operation codes it was possible to identify women who
underwent axillary lymph node sampling/dissection or
reconstructive/other plastic surgery to the breast at the
same time as the main mastectomy or BCS procedure.
Undergoing more than one procedure may lead to a
longer hospital stay.
Information regarding the managing NHS Trust and the
consultant in charge of each patient's care was derived
from the HES episode that detailed the chosen surgical
procedure. Consultant workloads were calculated as the
median number of cases treated per year. These were
divided into three groups; >= 40 cases, 41-80 cases and 81
or more cases, based on the premise that surgeons work
40 weeks per year and so the groups relate to those oper-
ating on less than one, between one and two, and more
than two patients per week. No other consultant-level
information is available from cancer registry or HES data
(such age, or years since qualification) and is not freely
available from other routine data sources. Information on
the number of beds in each hospital (as an indicator of
size) was obtained from the Department of Health Hospi-
tal Activity Statistics (number of general & acute beds
available, excluding neonates and children)[14]. These
were divided in to three roughly equal groups; less than
400, 400-799, 800 or more.
LOS was calculated as the difference between the admis-
sion date and discharge date. This was done using spells
rather than episodes, as a patient can have several finished
consultant episodes (FCEs) within one spell. For example,
they may have one FCE for the operation and initial mon-
itoring (lasting 2 days) and another FCE whilst they
recover in a different ward (lasting 3 days) giving a total
LOS of 5 days. LOS ranged from 0 to 170 days. There were
186 cases where a patient underwent a mastectomy and
had a hospital spell of less than two days; these were
excluded, as these patients are likely to have been trans-
ferred elsewhere but this has not been recorded. In some
hospitals, where a policy of early discharge has been
adopted, women undergoing BCS may have stays of less
than 2 days and so these records were included (3445
cases). Cases operated on by a consultant with a workload
of less than 10 per year were excluded to improve the reli-
ability of the LOS variable (these were mainly cases where
the consultant was incorrectly recorded as someone other
than the surgeon, such as the anaesthetist). This left 42
611 records for analysis. Variations in age at surgery,
tumour stage, comorbidities, lymph node sampling/dis-
section, reconstructive/plastic surgery to the breast(s),
consultant workload, number of hospital beds and
median LOS after surgery (the data were positively
skewed) by operation type, year and region were investi-
gated.
Statistical analysis
The data structure is clustered with patients nested within
surgical teams within NHS Trusts. To account for this clus-
tering we used multilevel poisson regression, using the
software MLwiN[15], which allows covariates (explana-
tory variables) to be incorporated in the model 'operating'
at the correct level of the system hierarchy. The model was
developed patients (level 1) clustered within surgical
teams (identified by the consultant surgeon) (level 2) and
NHS Trusts (level 3). The use of a Poisson model allowed
LOS to be transformed to a log scale, thereby accounting
for the skewed nature of the data. The resulting estimates
were exponentiated and presented as ratios, where values
<1.00 indicate a decreased LOS, values >1.00 indicate an
increased LOS and values of 1.00 indicate no change in
LOS according to the variable of interest.
The variables included in the model were operation type
(mastectomy/BCS), year of diagnosis, age (per 10 year
increase), stage at diagnosis (I, II, III, IV, missing), comor-
bidity score (0, 1+), lymph node excision (yes/no), recon-
structive/plastic surgery (yes/no) and region (all specified
at the patient level), consultant workload (10-40, 41-80,
81+) specified at the surgical team level and number of
hospital beds (<400, 400-799, 800+) specified at the Trust
level. When the model has run the total outcome varia-
tion is partitioned into that between patients but within
surgical teams and that between patients but within
Trusts, which indicates to what extent the unexplained
variation within the model pertains to differences across
surgeons or Trusts.
Results
Table 1 shows the characteristics of the study population
between 1997/98 and 2004/05 according to type of sur-
gery (mastectomy or BCS). Overall 24 734 out of 44 877
(55.1%) of women undergoing surgery had a mastectomy
and, over the study period, the proportion reduced from
58.4% to 52.3%. There was wide variation by NHS Trust
in the proportion of mastectomies, varying from 13.7% to
80.2% (Figure 1). The average age at surgery was 60 years
for the mastectomy patients and 58 years for the BCS
patients and this remained relatively stable over the study
period. The proportion with early stage (I/II) disease was
85.9% in the mastectomy group and 97.1% in the BCS
group (excluding those with missing stage, which
decreased over time) and this remained fairly constant
over the period of study. Overall 66.3% of the mastec-BMC Health Services Research 2009, 9:202 http://www.biomedcentral.com/1472-6963/9/202
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tomy group and 78.8% of the BCS group had no comor-
bidities and this decreased from 75.6% to 60.8% and
from 84.6% to 75.2% in the two groups over the 8 years.
Conversely, those scoring 4 or more increased from
19.9% to 30.2% (26.8% overall) in the mastectomy
patients and from 11.2% to 15.8% (14.8% overall) in the
BCS patients. The majority of patients underwent some
form of axillary node excision during their operation
(88.7% of mastectomy patients and 87.5% of BCS
patients) and this increased over time. The proportions
undergoing reconstructive or other plastic surgery to the
breast(s) during their operation were 15.1% and 2.8% of
the mastectomy and BCS groups respectively, and this
also increased slightly over the study period.
Median LOS decreased from 5 to 4 days for all surgery
patients; it decreased from 6 to 5 days for mastectomy
patients and remained at 3 days for BCS patients (Table
1). The same pattern was observed in both regions. Fig-
ures 2 and 3 show the median LOS for each Trust at the
start of the study period (1997/98) and at the end (2004/
05) along with the overall change between the two peri-
ods for the mastectomy and BCS patients respectively.
LOS after mastectomy decreased in 23 of the 35 Trusts,
whilst LOS after BCS decreased in 18 Trusts.
In univariable analyses having a mastectomy, increasing
age, advanced stage, presence of comorbidity, undergoing
reconstructive/plastic surgery, undergoing lymph node
excision and low consultant workload were associated
with increased LOS. LOS did not differ according to region
or number of hospital beds available and these variables
were dropped from further analyses.
Table 2 shows the results of the multivariable analyses.
When looking at LOS after the initial surgical procedure,
undergoing BCS was associated with 33% shorter stays
compared to undergoing mastectomy (LOS Ratio [LOSR]
= 0.67, 95%CI 0.66-0.68). Hospital stays were 21%
shorter in 2004/05 compared to 1997/98 (LOSR = 0.79,
95%CI 0.77-0.80). Older age was associated with an
increased LOS (11% increase [LOSR = 1.11, 95%CI 1.11-
1.11] per 10 year increase in age), as were advanced dis-
ease (18% increase [LOSR = 1.18, 95%CI 1.14-1.23] for
patients with stage IV compared to stage I disease) and
presence of comorbidities (8% increase [LOSR = 1.08,
95%CI 1.07-1.09] compared to no comorbidities).
Undergoing lymph node excision and reconstructive/
plastic surgery increased hospital stay by 8% each (LOSR
= 1.08, 95%CI 1.07-1.10 and LOSR = 1.08, 95%CI 1.06-
1.09 respectively). Consultant workload had no signifi-
cant association with LOS (LOSR = 0.96, 95%CI 0.89-1.02
and LOSR = 0.99, 95%CI 0.87-1.13 for medium and high
workloads compared to low workload).
The variance terms refer to the amount of residual (unex-
plained) variation at each of the levels. A figure of zero, or
close to zero, means that there is little or no residual vari-
Proportion of surgically treated women undergoing mastectomy and breast conserving surgery by NHS Trust (1997/98-2004/ 05) Figure 1
Proportion of surgically treated women undergoing mastectomy and breast conserving surgery by NHS Trust 
(1997/98-2004/05). NB: The NHS Trusts are numbered from highest to lowest percentage of mastectomies; the numbers in 
Figure 1 do not necessarily correspond with those in Figures 2 and 3.BMC Health Services Research 2009, 9:202 http://www.biomedcentral.com/1472-6963/9/202
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ation, i.e. all the variation at that level has been explained.
The results show that a small amount of variation
remained at the Trust and surgical team levels; 65.1% of
this was attributed to the Trust level and 34.9% to the sur-
gical team level. Comparison of this model to one with no
covariates (null model; not shown) shows that 31.4% of
the residual upper-level variation was explained by our
model.
In addition to measuring LOS for the initial surgical pro-
cedure (from the date of admission to the date of dis-
charge), we also calculated the total number of days spent
in hospital for breast cancer related conditions from the
date of operation to 30 days post operation (initial sur-
gery plus any subsequent admissions for a subset of con-
ditions including chemotherapy session, wound
infection, haematoma, cellulitis, pulmonary embolism,
problem related to implant/graft). The median LOS was 4
days. The proportion of women with a subsequent admis-
sion for one of the related conditions was 12.6%; the
majority of these admissions were for chemotherapy
(62.0%), followed by 'infection related to a procedure'
(12.2%). The multilevel regression results were very simi-
lar to the results for the initial surgery alone (Table 2). The
largest difference was seen for patients undergoing lymph
node excision where the association strengthened to 1.13
(95%CI 1.11-1.14). The level-specific variances were also
similar to the results for the initial surgery alone; 58.1%
was attributed to the Trust level and 48.9% to the surgical
team level. Compared to the null model (not shown)
34.8% of the residual upper-level variation was explained
by the model with covariates.
Table 1: Characteristics and length of stay of breast cancer patients between 1997/98 and 2004/05 by surgery group
Variable Group All 1997/98 1998/99 1999/00 2000/01 2001/02 2002/03 2003/04 2004/05
No. patients Mastectomy 24,734 2,309 2,905 3,102 3,104 3,192 3,291 3,399 3,432
BCS 20,143 1,646 2,170 2,333 2,391 2,588 2,803 3,077 3,135
All surgical 44,877 3,955 5,075 5,435 5,495 5,780 6,094 6,476 6,567
% patients Mastectomy 55.1 58.4 57.2 57.1 56.5 55.2 54.0 52.5 52.3
BCS 44.9 41.6 42.8 42.9 43.5 44.8 46.0 47.5 47.7
Average age (years) Mastectomy 60.7 60.4 60.0 60.4 60.4 61.1 60.8 61.6 60.9
BCS 58.8 59.1 58.3 58.3 58.2 58.5 59.0 59.2 59.2
Stage I (%) Mastectomy 25.3 19.3 24.6 25.7 26.0 26.0 25.8 25.7 27.6
BCS 53.3 41.3 53.5 51.8 54.4 53.7 54.8 55.0 56.7
Stage II (%) Mastectomy 53.7 39.1 55.7 54.7 55.6 55.8 54.1 55.3 55.3
BCS 38.0 32.3 38.0 40.3 38.8 39.1 37.6 38.1 37.9
Stage III (%) Mastectomy 1 1 . 3 9 . 21 1 . 21 1 . 61 0 . 21 1 . 01 2 . 41 2 . 51 1 . 7
BCS 2.0 1.9 2.0 2.3 1.8 2.0 2.1 1.9 1.7
Stage IV (%) Mastectomy 1.7 1.4 1.2 1.6 1.7 2.1 1.8 1.8 1.5
BCS 0.7 0.4 0.9 0.9 0.9 0.7 0.8 0.8 0.3
Stage missing (%) Mastectomy 8.0 31.1 7.2 6.4 6.5 5.1 5.9 4.7 3.9
BCS 6.0 24.2 5.5 4.7 4.1 4.5 4.6 4.3 3.4
Charlson 0 (%) Mastectomy 66.3 75.6 71.0 68.0 67.3 64.8 63.5 63.2 60.8
BCS 78.8 84.6 81.6 80.8 80.2 79.5 77.2 75.7 75.2
Charlson 1-3 (%) Mastectomy 6.8 4.5 5.7 6.7 6.7 6.4 6.9 7.9 9.0
BCS 6.5 4.1 5.3 5.8 6.1 5.4 6.4 7.3 9.0
Charlson 4+ (%) Mastectomy 26.8 19.9 23.3 25.3 26.0 28.7 29.5 28.9 30.2
BCS 14.8 11.2 13.1 13.4 13.8 15.1 16.5 17.1 15.8
Lymph node excision (%) Mastectomy 88.7 78.9 84.6 87.6 87.6 89.2 91.4 92.7 94.1
BCS 87.5 77.4 82.5 84.0 85.2 89.1 90.1 91.7 92.7
Reconstructive/plastic 
surgery (%)
Mastectomy 15.1 11.8 13.4 15.3 14.9 15.8 16.9 15.7 15.8
BCS 2.8 1.5 2.5 2.8 3.0 3.1 2.6 2.8 3.3
Median length of stay 
(days)
Mastectomy 566655555
BCS 333443333BMC Health Services Research 2009, 9:202 http://www.biomedcentral.com/1472-6963/9/202
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Median LOS for patients undergoing mastectomy in 1997/98 and 2004/05 and the change over the study period by NHS Trust Figure 2
Median LOS for patients undergoing mastectomy in 1997/98 and 2004/05 and the change over the study period 
by NHS Trust. NB: The NHS Trusts are numbered from highest to lowest LOS; the numbers in Figure 2 do not necessarily 
correspond with those in Figures 1 and 3.
Median LOS for patients undergoing breast conserving surgery in 1997/98 and 2004/05 and the change over the study period  by NHS Trust Figure 3
Median LOS for patients undergoing breast conserving surgery in 1997/98 and 2004/05 and the change over 
the study period by NHS Trust. NB: The NHS Trusts are numbered from highest to lowest LOS; the numbers in Figure 3 
do not necessarily correspond with those in Figures 1 and 2.BMC Health Services Research 2009, 9:202 http://www.biomedcentral.com/1472-6963/9/202
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Discussion
In this study women undergoing BCS had 33% shorter
hospital stays than women having a mastectomy. Over the
8 years the proportion of women undergoing mastectomy
decreased from 58% to 52%. During this time there was a
reduction in LOS of 21%, equivalent to a decrease of one
day (the median LOS at the start of the study was 5 days).
However, the change from mastectomy to BCS accounts
for only 9% of the observed decrease in LOS. Another pos-
sible reason for the reduction in LOS is an increase in the
number of women undergoing SLNB instead of axillary
node dissection (which is less invasive, thus requiring less
recovery time); however, we are unable to look in to this
further, as SNLB is a relatively new technique and is not
yet routinely coded in HES data. Some of these patients
may have been subsequently re-admitted for completion
of axillary node dissection after finding involved nodes in
the SLNB, but these should have been picked up in our
secondary analysis of the 30 day post-operation period. A
further explanation is an increase in the number of
women being admitted on the day of their operation
rather than the day before. Over the study period this
increased from 29% to 42% of patients, and thus may
account for some of the reduction in LOS. Other reasons
include increased adoption of early discharge and a
change in the criteria used to assess when women are fit
for discharge, however, the measurement of such policy
factors would involve the collection of more detailed data
and/or a survey of the staff within each Trust.
Using the 2008 NHS reference costs[16] as a guide the one
day decrease in LOS is equivalent to a saving of approxi-
Table 2: Associations between LOS and patient, treatment and organisational factors
Initial surgery 30 days post-op
LOS Ratio (95% CI) LOS Ratio (95% CI)
Mastectomy 1.00 1.00
BCS 0.67 (0.66-0.68) 0.66 (0.66-0.67)
1997/98 1.00 1.00
1998/99 0.96 (0.94-0.98) 0.92 (0.91-0.94)
1999/00 0.95 (0.93-0.97) 0.92 (0.90-0.94)
2000/01 0.93 (0.91-0.95) 0.89 (0.88-0.91)
2001/02 0.90 (0.89-0.92) 0.87 (0.85-0.89)
2002/03 0.87 (0.85-0.89) 0.85 (0.84-0.87)
2003/04 0.85 (0.83-0.86) 0.84 (0.82-0.86)
2004/05 0.79 (0.77-0.80) 0.78 (0.76-0.80)
Age (per 10 years) 1.11 (1.11-1.11) 1.08 (1.08-1.08)
Stage I 1.00 1.00
Stage II 1.06 (1.05-1.07) 1.08 (1.07-1.09)
Stage III 1.14 (1.13-1.16) 1.15 (1.13-1.17)
Stage IV 1.18 (1.14-1.23) 1.20 (1.15-1.24)
Missing 1.04 (1.02-1.06) 1.03 (1.01-1.05)
Comorbidities - No 1.00 1.00
Comorbidities - Yes 1.08 (1.07-1.09) 1.08 (1.07-1.10)
Nodes dissected - No 1.00 1.00
Nodes dissected - Yes 1.08 (1.07-1.10) 1.13 (1.11-1.14)
Reconstructive surg - No 1.00 1.00
Reconstructive surg - Yes 1.08 (1.06-1.09) 1.08 (1.06-1.10)
Consultant workload - 10-40 1.00 1.00
Consultant workload - 41-80 0.96 (0.89-1.02) 0.96 (0.89-1.03)
Consultant workload - 81+ 0.99 (0.87-1.13) 0.99 (0.90-1.09)
Variance (95% CI) Variance (95% CI)
Trust level 0.08 (0.04-0.13) 0.06 (0.03-0.10)
Surgical team level 0.05 (0.03-0.06) 0.04 (0.03-0.06)BMC Health Services Research 2009, 9:202 http://www.biomedcentral.com/1472-6963/9/202
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mately £600 per patient; a considerable amount given the
number of women undergoing breast surgery each year. In
reality however, the majority of the costs are incurred in
the first half of a hospital stay when assessment, interven-
tion and input from staff are at a maximum, whilst
decreases in LOS tend to result from a reduction in the sec-
ond half of the stay which are cheaper[6]. Nevertheless,
the trend towards shorter hospital stays allows more
patients to be treated.
The median LOS was 5 days for mastectomy patients, but
this varied from 3 to 8 days according to Trust. The
median LOS for BCS patients was lower at 3 days, but the
maximum was 7 days and there were some Trusts where
the median was 0 or 1 day. Such variation reflects differing
policies on the factors mentioned above. We are aware of
some Trusts treating the majority of women undergoing
BCS as day-cases and this will account for the low LOS in
these Trusts. We are also aware that several Trusts have
recently piloted 23-hour mastectomies, with patients
being discharged without drains and followed up at home
by nurses[17]. It has been shown that the use of drains
does not prevent seroma formation and is associated with
higher pain scores after surgery[18]. This change occurred
after the end of our study period and would not have
influenced our results, but we would expect LOS after
mastectomy to continue to reduce as 23-hour mastecto-
mies become more widespread.
There was also large variation in the proportion of women
undergoing mastectomy by Trust, ranging from 14% to
80%. This variation is well documented in reports from
the NHS Breast Screening Programme[19] and may be
due to the extent to which surgical choice is offered and
patients are made aware that it is their choice[20]. In this
study, which includes symptomatic patients who gener-
ally have larger and more advanced cancer, this effect is
probably magnified.
We used multilevel modelling to take account of the hier-
archical nature of the data and to estimate the amount of
unexplained variation attributable to each level. The Trust
and surgical team level variances were small but statisti-
cally significant. We included consultant workload in the
model, as a proxy for experience, but there was no signif-
icant relationship between workload and LOS. In addi-
tion, we included a measure of bed availability but this
showed no association with LOS. However, these meas-
ures may have been too crude to show any association.
The amount of variation was slightly higher at the Trust
level than the surgical team level. It has been suggested
that doctors working within the same hospital conform to
the practice of immediate colleagues, resulting in smaller
within doctor variation and larger within hospital varia-
tion[12]. It would appear that Trust policies, such as the
uptake of early discharge, have a substantial effect on LOS,
but such factors are not captured within routine data and,
as mentioned earlier, would involve the collection of
more detailed data tailored towards the answering of spe-
cific research questions. Such measures could be devel-
oped in future work, for example, guidelines for LOS and
the categories of patients which can safely be treated as
day cases, as well as the education of staff within breast
teams, should help reduce the current level of variation.
In this study we excluded cases treated by surgeons with a
workload less than 10 per year and mastectomy cases
where the LOS was zero or one day, as it was felt that the
data were unreliable and likely to have been recorded
incorrectly. To test the effect of these assumptions the
analysis was repeated including all cases but there was no
substantial change to the fixed effects. The variances, how-
ever, were larger, particularly at the surgical team level,
reflecting the amount of unexplained variation being
added.
The factors affecting LOS are complex and not necessarily
associated with quality of care, and there is little evidence
of any relation between LOS and outcome[21]. In order to
look further into this issue we also looked at the total
number of days spent in hospital in the 30 days following
the breast cancer surgery and attempted to identify admis-
sions specifically related to the breast cancer. The median
LOS in the 30 days was 4 days, very similar to the LOS for
the initial surgery. According to the data 13% of women
in this study were re-admitted for reasons related to their
breast cancer, but the majority of these admissions were
for women to receive chemotherapy, suggesting that few
women are readmitted with complications related to their
breast cancer surgery. However, it is unclear how complete
and accurate the coding of secondary diagnoses in HES is
and so it is possible that these figures are an underesti-
mate.
Conclusion
In summary, the number of days spent in hospital after
surgery for breast cancer has continued to decline for sev-
eral decades. It is likely that the reductions in LOS are
partly due to changes in surgical technique (increasing
proportions of BCS and SLNB) and partly due to changes
in practice (admission on day of surgery and earlier dis-
charge). However, this study has identified wide variation
in practice with substantial cost implications for the NHS.
Further work is required to explain the present situation of
substantial variation of LOS amongst Trusts and surgical
teams.
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